Effects of Recombinant Human Growth Hormone in Elderly Patients With Moderate to Severe Acute Brain Injury (GH-ABI-RCT)

Clinical trial NCT07481656 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07481656
Sponsor: Anhui Provincial Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Acute Brain Injuries Moderate to Severe Traumatic Brain Injury

Start date: 2026-04-10
Primary completion: 2027-09-30
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.